Keywords
References
-
1.
Saito O, Saito T, Asakura S, Akimoto T, Inoue M, Ando Y, et al. Effects of raloxifene on bone metabolism in hemodialysis patients with type 2 diabetes. Int J Endocrinol Metab. 2012;10(2):464-9. https://doi.org/10.5812/ijem.3794.
-
2.
Libetta C, Sepe V, Esposito P, Galli F, Dal Canton A. Oxidative stress and inflammation: Implications in uremia and hemodialysis. Clin Biochem. 2011;44(14-15):1189-98. [PubMed ID: 21777574]. https://doi.org/10.1016/j.clinbiochem.2011.06.988.
-
3.
Stanton RC. Oxidative stress and diabetic kidney disease. Curr Diab Rep. 2011;11(4):330-6. [PubMed ID: 21557044]. https://doi.org/10.1007/s11892-011-0196-9.
-
4.
Ozgocmen S, Kaya H, Fadillioglu E, Yilmaz Z. Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Arch Med Res. 2007;38(2):196-205. [PubMed ID: 17227729]. https://doi.org/10.1016/j.arcmed.2006.09.010.
-
5.
Ozgocmen S, Kaya H, Fadillioglu E, Aydogan R, Yilmaz Z. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem. 2007;295(1-2):45-52. [PubMed ID: 16841180]. https://doi.org/10.1007/s11010-006-9270-z.
-
6.
Kaya H, Ozkaya O, Sezik M, Arslanoglu E, Yilmaztepe A, Ulukaya E. Effects of raloxifene on serum malondialdehyde, erythrocyte superoxide dismutase, and erythrocyte glutathione peroxidase levels in healthy postmenopausal women. Maturitas. 2005;50(3):182-8. [PubMed ID: 15734599]. https://doi.org/10.1016/j.maturitas.2004.05.005.
-
7.
Mackinnon ES, Rao AV, Josse RG, Rao LG. Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal women. Osteoporos Int. 2011;22(4):1091-101. [PubMed ID: 20552330]. https://doi.org/10.1007/s00198-010-1308-0.